David Chang, Allogene (Jeff Rumans)
Allogene spotlights their off-the-shelf CAR-T contender ‘501 with a snapshot on CRs and no GVHD
Allogene execs are out to revolutionize a field they played a major role in pioneering. And they will arrive — virtually — at ASCO with some …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
